Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

(2018) Alessandro Mantovani et al.   DIABETES CARE

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

(2018) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care

(2017) Marloes van Asten et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity

(2016) Pierre Bedossa et al.   GUT

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?-In principle yes, in practice not yet

(2016) Mary E. Rinella   HEPATOLOGY

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

(2016) Claudia Sanna et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes

(2016) Vincent Wai-Sun Wong et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007–14

(2016) F D Richard Hobbs et al.   LANCET

Practical approach to non-alcoholic fatty liver disease in patients with diabetes

(2015) F. W. D. Tai et al.   DIABETIC MEDICINE

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Ethnicity and the diagnosis gap in liver disease: a population-based study

(2014) William Alazawi et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Liver transplantation and non-alcoholic fatty liver disease

(2014) Petros Zezos   WORLD JOURNAL OF GASTROENTEROLOGY

Non-alcoholic fatty liver disease

(2014) N. Sattar et al.   BMJ-British Medical Journal

Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study

(2014) Helen Booth et al.   Lancet Diabetes & Endocrinology

Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey

(2013) Rosa Gini et al.   BMC PUBLIC HEALTH

The strength of primary care in Europe: an international comparative study

(2013) Dionne Kringos et al.   BRITISH JOURNAL OF GENERAL PRACTICE

From NAFLD in clinical practice to answers from guidelines

(2013) Fabio Nascimbeni et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up

(2013) Shira Zelber-Sagi et al.   LIVER INTERNATIONAL

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries

(2013) Preciosa M Coloma et al.   BMJ Open

Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project

(2012) Paul Avillach et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

(2011) R. M. Williamson et al.   DIABETES CARE

Interrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 Diabetes

(2011) Ki-Chul Sung et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project

(2010) Preciosa M. Coloma et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

(2009) Cecilia Söderberg et al.   HEPATOLOGY